Massachusetts General Hospital

NEW ORLEANS — Patients with type 2 MI are not only rarely referred to cardiac rehabilitation, but they are even less likely to attend.

Adults with body dysmorphic disorder benefited from both cognitive behavioral therapy and supportive psychotherapy, findings published in JAMA Psychiatry revealed.

In this video exclusive, Kenneth Rosenfield, MD, MHCDS, discusses recent advancements and ongoing challenges in addressing the “international crisis” of pulmonary embolism.

ORLANDO — Results presented at the Current Concepts in Joint Replacement Winter Meeting showed patients undergoing total hip arthroplasty who received highly crosslinked polyethylene liners experienced less long-term linear and volumetric wear compared with conventional polyethylene liners

Over the next few years, opioid misuse and overdose deaths are projected to substantially increase despite current efforts to prevent abuse, according to findings published in JAMA Network Open.

Patients with HIV were more likely to have cardiac dysfunction, according to a systematic review and meta-analysis published in JACC: Heart Failure.

In recent years, data have emerged showing a variety of medical therapies can improve outcomes of patients with peripheral artery disease.

Consolidation therapy with durvalumab for patients with stage III non-small cell lung cancer represented a cost-effective use of an expensive immunotherapy, according to study published in JAMA Oncology.

SAN ANTONIO — The addition of alpelisib to fulvestrant nearly doubled PFS among patients with PIK3CA-mutant, hormone receptor-positive, HER2-negative advanced breast cancer who progressed on or after prior aromatase inhibitor therapy, according to results of the randomized phase 3 SOLAR-1 trial presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — Accelerated partial breast irradiation appears close but not equivalent to whole breast irradiation for control of ipsilateral breast tumor recurrence and risk for relapse-free interval events, according to results of a randomized phase 3 trial presented at San Antonio Breast Cancer Symposium.